Balyasny Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,073
| Closed | -$15.5M | – | 2810 |
|
|
2024
Q4 | $15.5M | Buy |
+47,073
| New | +$16M | 0.04% | 772 |
|
|
2024
Q1 | – | Sell |
-15,730
| Closed | -$5.08M | – | 2628 |
|
|
2023
Q4 | $5.08M | Buy |
+15,730
| New | +$4.93M | 0.01% | 1106 |
|
|
2023
Q1 | – | Sell |
-67,043
| Closed | -$28.2M | – | 2670 |
|
|
2022
Q4 | $28.2M | Buy |
+67,043
| New | +$27.1M | 0.1% | 343 |
|
|
2022
Q3 | – | Sell |
-54,343
| Closed | -$26.9M | – | 2864 |
|
|
2022
Q2 | $26.9M | Sell |
54,343
-28,464
| -34% | -$14.8M | 0.11% | 325 |
|
|
2022
Q1 | $46.6M | Buy |
82,807
+32,082
| +63% | +$19.3M | 0.21% | 161 |
|
|
2021
Q4 | $38.3M | Buy |
+50,725
| New | +$38M | 0.16% | 204 |
|
|
2021
Q3 | – | Sell |
-50,518
| Closed | -$37.8M | – | 1961 |
|
|
2021
Q2 | $32.5M | Buy |
+50,518
| New | +$30.7M | 0.18% | 162 |
|
|
2021
Q1 | – | Sell |
-19,522
| Closed | -$11.4M | – | 1770 |
|
|
2020
Q4 | $11.4M | Buy |
19,522
+11,634
| +147% | +$6.63M | 0.07% | 406 |
|
|
2020
Q3 | $4.07M | Sell |
7,888
-19,194
| -71% | -$9.72M | 0.04% | 669 |
|
|
2020
Q2 | $12.2M | Buy |
+27,082
| New | +$12M | 0.13% | 294 |
|
|
2018
Q4 | – | Sell |
-8,956
| Closed | -$2.8M | – | 1413 |
|
|
2018
Q3 | $2.8M | Sell |
8,956
-25,133
| -74% | -$7.8M | 0.02% | 888 |
|
|
2018
Q2 | $9.84M | Sell |
34,089
-8,324
| -20% | -$2.3M | 0.05% | 491 |
|
|
2018
Q1 | $10.6M | Buy |
42,413
+41,355
| +3,909% | +$10.5M | 0.05% | 508 |
|
|
2017
Q4 | $253K | Buy |
+1,058
| New | +$256K | ﹤0.01% | 1810 |
|
|
2017
Q3 | – | Sell |
-1,644
| Closed | -$372K | – | 1885 |
|
|
2017
Q2 | $372K | Sell |
1,644
-23,566
| -93% | -$5.14M | ﹤0.01% | 1271 |
|
|
2017
Q1 | $5.03M | Buy |
25,210
+4,486
| +22% | +$864K | 0.03% | 703 |
|
|
2016
Q4 | $3.78M | Buy |
+20,724
| New | +$3.53M | 0.02% | 762 |
|
|
2016
Q2 | – | Sell |
-1,600
| Closed | -$219K | – | 1174 |
|
|
2016
Q1 | $219K | Buy |
+1,600
| New | +$210K | ﹤0.01% | 1099 |
|
|
2015
Q4 | – | Sell |
-1,612
| Closed | -$217K | – | 1245 |
|
|
2015
Q3 | $217K | Buy |
+1,612
| New | +$232K | ﹤0.01% | 996 |
|
Other funds holding BIO
VAM
AI
